Scope
The AHA highlights describe prevention, detection and management of high blood pressure in adults. They combine blood-pressure categories and average-pressure thresholds with clinical cardiovascular disease, comorbidity and PREVENT risk when deciding on medication. The general target has population-specific qualifications. Lifestyle measures, access to care and reliable home measurements remain part of management. This summary is limited to the official highlights and does not supply the full guideline’s measurement protocol, drug-dose tables or special-population pathways.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Classify blood pressure and set the goal
- Normal blood pressure requires systolic pressure <120 mm Hg and diastolic pressure <80 mm Hg. Elevated blood pressure is systolic 120 to 129 mm Hg with diastolic <80 mm Hg. [1]
- Stage 1 hypertension is systolic 130 to 139 mm Hg or diastolic 80 to 89 mm Hg. Stage 2 is systolic ≥140 mm Hg or diastolic ≥90 mm Hg. [1]
- The overarching adult treatment goal is <130/80 mm Hg, with additional considerations for people requiring institutional care, those with limited predicted lifespan and pregnant patients. [1]
Lifestyle measures and access to care
- Strongly recommended lifestyle measures include a healthy weight, a heart-healthy dietary pattern such as DASH, less sodium, more dietary potassium, moderate physical activity, stress management, and reduction or elimination of alcohol. [1]
- Work with community and health-system partners on adult screening. Multidisciplinary care should identify medication-access problems and other structural barriers to blood-pressure control. [1]
When to start medication
- Add medication to lifestyle measures for adults with average blood pressure ≥140/90 mm Hg. At average blood pressure ≥130/80 mm Hg, medication is recommended for selected adults with clinical cardiovascular disease, previous stroke, diabetes, chronic kidney disease, or PREVENT 10-year cardiovascular risk ≥7.5%. [1]
- For the lower-risk pathway, adults with PREVENT 10-year cardiovascular risk <7.5% and average blood pressure ≥130/80 mm Hg should start medication if average pressure remains ≥130/80 mm Hg after a 3- to 6-month initial lifestyle trial. [1]
- For stage 2 hypertension, starting 2 first-line agents from different classes in one fixed-dose combination pill is preferred to 2 separate pills, to improve adherence and shorten time to control. [1]
Home monitoring and severe hypertension
- Use home blood-pressure monitoring alongside frequent contact with a multidisciplinary team and standardised measurement and treatment protocols. Avoid relying on cuffless devices, including smartwatches, for accurate readings until their precision and reliability improve. [1]
- For nonpregnant people with blood pressure >180/120 mm Hg and no evidence of acute target-organ damage, evaluate and treat in the outpatient setting, with timely initiation, restarting or intensification of oral antihypertensive medication. [1]
Limitations and use
- The official highlights supply selected recommendations only. They do not give drug-specific doses, contraindications or the full evidence tables.
- The general treatment goal has explicit qualifications for pregnancy, institutional care and limited predicted lifespan; the highlights do not define the alternative targets or complete pathways.
- The outpatient severe-hypertension statement requires absence of acute target-organ damage and does not establish management when damage is present.
- The extract does not provide PREVENT equations or a complete blood-pressure measurement and diagnostic-confirmation protocol.
- This House summary is based on the linked focused or condensed recommendation sources; it does not represent the complete original publication.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- High blood pressure in adults — focused recommendation source
Selected recommendation material consulted
Publication details
- Issuing organisation
- ACC / AHA
- First published
- 14 August 2025
- Resource type
- Clinical guideline · House clinical summary
Earlier House summaries: hypertension in adults aha
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.